{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Larsen FT"],"funding":["The Graduate School of Science and Technology at Aarhus University","Danish Heart Foundation","The Graduate School of Health at Aarhus University"],"pagination":["215-220"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5321689"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["61(2)"],"pubmed_abstract":["Primary brain calcification (PBC) is a neurodegenerative disorder characterized by calcium-phosphate deposits in the basal ganglia and often also other areas of the brain. The prevalent clinical manifestations are cognitive impairment, neuropsychiatric symptoms, and movement disorders. In recent years, monoallelic variants in SLC20A2, which encodes the type III sodium-dependent inorganic phosphate (P<sub>i</sub>) transporter 2 (PiT2), have been linked to the familial form of PBC in 40-50% of the families reported worldwide as well as to sporadic cases of PBC. Further insight into the disease mechanism is, however, needed. Based on co-expression studies of wild-type and variant PiT2 in Xenopus laevis oocytes, the molecular disease mechanism associated with SLC20A2 missense variants has form"],"journal":["Journal of molecular neuroscience : MN"],"pubmed_title":["Primary Brain Calcification Causal PiT2 Transport-Knockout Variants can Exert Dominant Negative Effects on Wild-Type PiT2 Transport Function in Mammalian Cells."],"pmcid":["PMC5321689"],"funding_grant_id":["15-R99-A5905-22947"],"pubmed_authors":["Jensen N","Autzen JK","Kongsfelt IB","Pedersen L","Larsen FT"],"additional_accession":[]},"is_claimable":false,"name":"Primary Brain Calcification Causal PiT2 Transport-Knockout Variants can Exert Dominant Negative Effects on Wild-Type PiT2 Transport Function in Mammalian Cells.","description":"Primary brain calcification (PBC) is a neurodegenerative disorder characterized by calcium-phosphate deposits in the basal ganglia and often also other areas of the brain. The prevalent clinical manifestations are cognitive impairment, neuropsychiatric symptoms, and movement disorders. In recent years, monoallelic variants in SLC20A2, which encodes the type III sodium-dependent inorganic phosphate (P<sub>i</sub>) transporter 2 (PiT2), have been linked to the familial form of PBC in 40-50% of the families reported worldwide as well as to sporadic cases of PBC. Further insight into the disease mechanism is, however, needed. Based on co-expression studies of wild-type and variant PiT2 in Xenopus laevis oocytes, the molecular disease mechanism associated with SLC20A2 missense variants has form","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Feb","modification":"2025-04-04T21:21:13.855Z","creation":"2019-03-27T02:37:08Z"},"accession":"S-EPMC5321689","cross_references":{"pubmed":["27943094"],"doi":["10.1007/s12031-016-0868-7"]}}